Valued at a market cap of $3.4 billion, Hims & Hers Health (HIMS) operates a telehealth consultation platform that connects consumers to healthcare professionals and enables them to access medical care for mental health, sexual health, dermatology, and primary care.
The stock went public in 2019, and has returned 61% since then. HIMS stock trades 37.6% below all-time highs despite its recent rally, with the shares up over 28% in the last month.
